                         SEQUENCE LISTING

<110>  King's College London
 
<120>  COMPOSITIONS AND METHODS

<130>  |P10678GBWO|

<140>  PCT/GB2021/050485
<141>  2021-02-25

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Compound


<220>
<221>  X2
<222>  (2)..(2)
<223>  cyclohexylalanine (Cha)

<220>
<221>  X3
<222>  (3)..(3)
<223>  cyclohexylalanine (Cha)

<400>  1

Phe Xaa Xaa Arg Lys Pro Asn Asp Lys 
1               5                   


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic compound (PTL032 and/or PTL0GC1)

<400>  2

Lys Ser Ser Lys Ser Pro Ser Lys Lys Asp Asp Lys Lys Pro Gly Asp 
1               5                   10                  15      


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic compound (PTL032 - including Cysteine residue)

<400>  3

Lys Ser Ser Lys Ser Pro Ser Lys Lys Asp Asp Lys Lys Pro Gly Asp 
1               5                   10                  15      


Cys 
    


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic compound (PTL0GC1 - including Lysine residue)

<400>  4

Lys Ser Ser Lys Ser Pro Ser Lys Lys Asp Asp Lys Lys Pro Gly Asp 
1               5                   10                  15      


Lys 
    


